AI & Imaging

Pulmera CBeam gains FDA clearance for intraoperative 3D imaging

Pulmera’s platform attaches to conventional 2D surgical C-arms and reconstructs rotational X-ray images into 3D datasets for intraoperative visualization.

Pulmera’s CBeam platform has received U.S. FDA 510(k) clearance for intraoperative 3D imaging, according to a company announcement. The system is designed to work with conventional 2D surgical C-arms rather than requiring a separate 3D imaging system.

CBeam uses a position-sensor-based setup that attaches to widely installed surgical C-arms. During a rotational scan, the platform captures a series of X-ray images and reconstructs them into a 3D dataset for intraoperative visualization.

The cleared use covers orthopedic and neurological surgical procedures. Pulmera said the platform is intended for imaging high-contrast objects, bones, joints, maxillofacial anatomy, the cervical, thoracic and lumbar spine, pelvis, acetabulum, and fractures of the upper and lower extremities.

The company is positioning CBeam as a way to extend 3D imaging access through existing C-arm infrastructure. Pulmera cited more than 30,000 active C-arms in U.S. hospitals as the installed base for potential use.

Pulmera’s website describes CBeam as a system for converting existing X-ray C-arms into 3D imaging tools. The company has linked the FDA clearance announcement from its product page.

Share

About the author

RadiologySignal.com writers

Editorial Team

Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.

More from this section